Our publications

  1. Home
  2.  » Publications

Collaborating with top academic partners, Ksilink’s scientists publish regularly in scientific reviews. ​

Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.

June 2024, Translational Psychiatry
Read more

Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation.

January 2024, Stem Cell Research& Therapy​
Read more

Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls.

December 2023, Scientific reports
Read more

Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9.

October 2023, Stem Cell Research​
Read more

Addressing Global Environmental Challenges to Mental Health Using Population Neuroscience: A Review.

October 2023, JAMA Psychiatry​
Read more

Revealing invisible cell phenotypes with conditional generative modeling.

October 2023, Nature Communications​
Read more

Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.

September 2023, Preprint​
Read more

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons.

July 2023, JoVE Journal​
Read more

Effects of urban living environments on mental health in adults.

June 2023, Nature Medicine ​
Read more

Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid.

December 2022, Cancer Biology & Therapy​
Read more

CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.

November 2022, Nature Communications​
Read more

High-content phenotyping of Parkinson’s disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification.

September 2022, Stem Cell Reports​
Read more

Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.

June 2022, International Journal of Molecular Sciences​
Read more

JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations

March 2022, Preprint​
Read more